Registered entities
Glympse Bio, Inc.
Reg. No. 474956987United States
AVGSF - Glympse Bio 2020
Reg. No. 1810710United States
Innovation
17 patent families (3 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace slowing. Cited 528 times.
| Year | Filings |
|---|---|
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 13 |
| 2024 | 5 |
| 2025 | 3 |
Investor mix
20 investors on record; lead investors include Polaris Partners, Arch Venture Partners, Array, Array; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 50% |
| Private equity | 2 | 10% |
| Accelerator & incubator | 1 | 5% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 6 | 30% |